ADC Therapeutics Tumbles On Phase 3 Trial Safety Concerns, Joins Other Big Stocks Moving Lower In Thursday's Pre-Market Session (CORRECTED)

Benzinga_recent_news06-07

Editor’s note: This story and its headline have been updated to accurately reflect the reasons for the moves in 3D Systems (DDD) and ADC Therapeutics (ADCT) shares. U.S. stock futures were lower this ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2641785321?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=240,dpr=2,format=auto,quality=85/files/images/story/2026/06/06/Investors-Show-Virtual-Screen-Stock-Mark.jpeg","is_english":true,"pubTime":"2026-06-07 04:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2641785321","market":"us","top_or_hot":-1,"title":"ADC Therapeutics Tumbles On Phase 3 Trial Safety Concerns, Joins Other Big Stocks Moving Lower In Thursday's Pre-Market Session (CORRECTED)","media":"Benzinga_recent_news","content":"<div>\n<p>Editor’s note: This story and its headline have been updated to accurately reflect the reasons for the moves in 3D Systems (DDD) and ADC Therapeutics (ADCT) shares.\nU.S. stock futures were lower this ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/06/52996768/adc-therapeutics-posts-downbeat-q1-earnings-joins-julong-holding-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ADC Therapeutics Tumbles On Phase 3 Trial Safety Concerns, Joins Other Big Stocks Moving Lower In Thursday's Pre-Market Session (CORRECTED)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nADC Therapeutics Tumbles On Phase 3 Trial Safety Concerns, Joins Other Big Stocks Moving Lower In Thursday's Pre-Market Session (CORRECTED)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-07 04:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/26/06/52996768/adc-therapeutics-posts-downbeat-q1-earnings-joins-julong-holding-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Editor’s note: This story and its headline have been updated to accurately reflect the reasons for the moves in 3D Systems (DDD) and ADC Therapeutics (ADCT) shares.\nU.S. stock futures were lower this ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/06/52996768/adc-therapeutics-posts-downbeat-q1-earnings-joins-julong-holding-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADC","symbol_name":"艾格里房产","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/26/06/52996768/adc-therapeutics-posts-downbeat-q1-earnings-joins-julong-holding-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session","article_id":"2641785321","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=240,dpr=2,format=auto,quality=85/files/images/story/2026/06/06/Investors-Show-Virtual-Screen-Stock-Mark.jpeg"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/06/52996768/adc-therapeutics-posts-downbeat-q1-earnings-joins-julong-holding-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2641785321","pubTimestamp":1780776240,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"U.S. stock futures down on tech profit-taking and weak guidance, ADC Therapeutics shares plunge 50.67%, other stocks also slide.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ADC":"艾格里房产","BK4170":"电脑硬件、储存设备及电脑周边","BK4139":"生物科技","BK4161":"工业机械","BK4546":"3D打印","ADCT":"ADC Therapeutics SA","BK4231":"零售房地产信托","BK4551":"寇图资本持仓","LENZ":"Therapeutics","BK4007":"制药","BK4588":"碎股","BK4080":"零售业房地产投资信托","BK4539":"次新股","BK4505":"高瓴资本持仓","BK4585":"ETF&股票定投概念","DDD":"3D系统"},"translate_title":"ADC Therapeutics因3期试验安全担忧而暴跌，与其他大型股一起在周四盘前交易中走低（更正）","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADCT":1,"ADC":1.5,"DDD":1,"LENZ":1.5},"content_text":"Editor’s note: This story and its headline have been updated to accurately reflect the reasons for the moves in 3D Systems (DDD) and ADC Therapeutics (ADCT) shares.\nU.S. stock futures were lower this morning, with the Nasdaq futures falling around 0.89% on Thursday following tech sector profit-taking and disappointing corporate guidance from major apparel and infrastructure giants.\nShares of ADC Therapeutics SA (NYSE:ADCT) plummeted in pre-market trading due to trial safety concerns.\nThe massive sell-off came after the top-line data from its Phase 3 LOTIS-5 trial, which evaluates a combination regimen of its FDA-approved lymphoma therapy, Zynlonta.\nZynlonta is an antibody-drug conjugate is sold under an accelerated FDA approval pathway, making positive confirmatory data mandatory for it to stay on the U.S. market. Though the Swiss biotech stated that the trial successfully hit its primary progression-free survival endpoint with statistical significance in heavily pre-treated r/r DLBCL patients, underlying trial details triggered the sell-off.\nADC Therapeutics shares dipped 50.67% to $1.52 in pre-market trading.\nHere are some other stocks moving lower in pre-market trading:\nPhoto: Thapana_Studio via Shutterstock\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2641785321","isCrawlerRequest":true}